To find whether inhibition of Hsp90 may affect flagellin-induced activation of human myeloid leukemia cells, bacterial flagellin-induced NF-κB activation of THP-1 cells in the presence of Hsp90 inhibitor was examined by NF-κB/AP-1 reporting assay. Here, NFKB1 is linked to myeloid leukemia.